Michael Graves is listed as a director on 1 SEC Form D filing by 1 issuer in Nov 2016: EAGLE PHARMACEUTICALS, INC. (Woodcliff Lake, NJ — pharmaceuticals — 2016; $12.3M reported sold to 18 investors).
What this means One deal on file with the SEC, filed Nov 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Michael Graves and found 5 differences: Bankruptcy case: Glenning Company, LLC; Michael Graves appears on 1 deal that stopped filing before reaching its target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.